acquisition

European Commission Approves Intel Acquisition of McAfee

The European Commission on Wednesday approved Intel's $7.68 billion acquisition of security-software company McAfee. Regulators had been concerned that the deal would exclude competing software from working with Intel processors, but Intel agreed to maintain interoperability.

M&A Mania: Early 2011 Deals Already Hit a 10-Year High

Companies such as Duke Energy and DuPont are off and running with megamergers early this year. Even Playboy is among the dealers. And market pros say the trend is far from over. Why are so many U.S. companies tying the knot? Fast growth is hard to come by in any other strategy.

Tech Takeovers: Nine Good Bets for 2011 Stock Gains

Even after a round of acquisitions in 2010, some big tech companies are still rolling in cash -- and 2011 looks like another promising year for tech mergers. Here's columnist Peter Cohan's list of top tech acquisition targets for 2011.

Groupon Rejects Google: Is It Aiming for a Big IPO Instead?

Groupon has turned down Google's acquisition offer of roughly $6 billion. It might be holding out for more money, but columnist Alex Salkever thinks it's more likely to be aiming for a big IPO. Here's why he believes its offering could launch a whole new wave of Internet IPOs.

That's a Wrap: Miramax Films Sale Finally Closes

After months of delays, the deal is done: An investment group called Filmyard Holdings is the proud new owner of the storied Miramax Films. The sale was announced back in June, but concerns about bank financing pushed the closing date back until now.

Google's Latest Tech Buys: Video and Voice-Activated Search

Google has bought speech-synthesis software maker Phonetic Arts and video-distribution technology firm Widevine Technologies, the company announced in blog posts Friday. These firms are the latest to be snapped up as Google continues to buy technology at a rapid pace.

Big Tech's Buying Binge: Who Will Be Acquired Next?

IBM, Oracle, Hewlett Packard and Intel have been on a buying spree of late, and it's virtually guaranteed that they'll be purchasing more companies over the next several months. But which companies will they target next? Here are eight strong possibilities you might want to buy into.

CNBC Anchor's Book Is a Fly on the Wall for Lehman's Fall

This week marks the second anniversary of an event that shook the financial industry to its core. In her newly released book, The Weekend that Changed Wall Street, CNBC anchor Maria Bartiromo gives an insider's look at the fateful days surrounding the fall of Lehman Brothers.

Bristol-Myers Squibb to Buy ZymoGenetics for $885 Million

Drugmaker Bristol-Myers Squibb plans to buy ZymoGenetics, its partner in developing a hepatitis C treatment, for $885 million. The move is part of a trend of pharmaceutical acquisitions as several big patents face expiration soon.